P-946 Why do non smokers with non-small cell lung cancer...

P-946 Why do non smokers with non-small cell lung cancer (NSCLC) who receive erlotinib have better clinical outcomes than smokers?

Clark, G., Cagnoni, P., Ptaszynski, M., Hamilton, M., Santabárbara, P., Christy-Bittel, J., Geiger, B., McCarthy, S., Onetto, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81439-4
Date:
July, 2005
File:
PDF, 149 KB
english, 2005
Conversion to is in progress
Conversion to is failed